Product Information
ROSUVASTATIN CALCIUM 5 MG TAB is a generic product labeled by PuraCap Laboratories LLC, priced at $0.0321 per EA under NDC 24658026190. Its NADAC has been published 159 times since Sep 20, 2023.
FDA first approved this application on Oct 31, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
PuraCap Laboratories LLCNDC
24658026190
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ROSUVASTATIN CALCIUMApproval Type
Generic (ANDA)
FDA Application
ANDA207752FDA Approved
10/31/2016
TE Code
AB
On Market Since
8/23/2023
Pharmacological Classes
Price Statistics
The NADAC for ROSUVASTATIN CALCIUM 5 MG TAB has been published 159 times since Sep 20, 2023, and over the history we have for it it has declined 32.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0321 per EA |
|---|---|
| All-time high | $0.0523 (Dec 13, 2023) |
| All-time low | $0.0321 (Sep 23, 2026) |
| 52-week high | $0.0385 |
| 52-week low | $0.0321 |
| Median price | $0.0385 |
| Average price | $0.0389 |
| Largest weekly change | -22.3% (Dec 20, 2023) |
| Weeks tracked | 159 |
| Tracking since | Sep 20, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ROSUVASTATIN CALCIUM market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
PuraCap Laboratories LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ROSUVASTATIN CALCIUM market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
HMG-CoA Reductase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ROSUVASTATIN CALCIUM 5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for ROSUVASTATIN CALCIUM 5 MG TAB, manufactured by PuraCap Laboratories LLC, is $0.0321 per EA (NDC 24658026190), effective Sep 30, 2026.
How has the price of ROSUVASTATIN CALCIUM 5 MG TAB changed over time?
Over the history we have for it, the NADAC for ROSUVASTATIN CALCIUM 5 MG TAB has declined 32.7%. It has been tracked across 159 weekly CMS publications since Sep 20, 2023.
What are the highest and lowest recorded NADAC prices for ROSUVASTATIN CALCIUM 5 MG TAB?
Since Sep 20, 2023, the NADAC for ROSUVASTATIN CALCIUM 5 MG TAB has ranged from a low of $0.0321 (Sep 23, 2026) to a high of $0.0523 (Dec 13, 2023), with a median of $0.0385 per EA.
Are there cheaper alternatives to ROSUVASTATIN CALCIUM 5 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of ROSUVASTATIN CALCIUM 5 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ROSUVASTATIN CALCIUM 5 MG TAB?
ROSUVASTATIN CALCIUM 5 MG TAB (NDC 24658026190) is labeled by PuraCap Laboratories LLC, and CMS classifies it as a generic product.